18 and older, any sex, with Strategy Training. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Mean Patient-therapist Communication ScorePrimary· Baseline to Post-Intervention (up to 3 weeks)
Measure of Participation in Conversation (MPC) Interaction score greater than or equal to 2. The scale assesses the degree of participation executed by the participant with communication impairment during supported conversation. Scores range from 0=no participation/comprehension to 4=full participation/comprehension.
Group
Value
95% CI
Strategy Training
3.0
± 1.0
Change in Independence With Daily ActivitiesSecondary· Baseline to 6 months
Change in independence measured with the Functional Independence Measure. The FIM assesses 18 tasks in 6 functional domains (self-care, sphincter control, transfers, locomotion, communication and social cognition) using a scale of 1 (dependent) to 7 (independent). Scores range from 18 to 126. Higher values represent better outcomes. The a priori criterion for change was a medium effect size of change (Cohen's d≥0.5).
Group
Value
95% CI
Strategy Training
51.7
± 21.0
Change in CognitionSecondary· Baseline to 6 months
Change in cognition measured with the Cognitive Linguistic Quick Test Executive Function Score. The severity score measures executive functions using 4 tasks (symbol trails, generative naming, mazes, and design generation). The score ranges from 40 (within normal limits) to 0 (severe impairment). Higher values represent better outcomes. The a priori criterion for change was a medium effect size of change (Cohen's d≥0.5).
Group
Value
95% CI
Strategy Training
1.8
± 3.5
Sponsor's own description
One-third to one-half of acute strokes result in newly acquired cognitive impairments. Approximately 30 to 40% of people in the acute phase of stroke also sustain communication impairments. Stroke-related cognitive impairments are associated with significant functional disability, as indicated by the inability to regain independence in daily activities. The overall aim of this study is to examine the feasibility of an adapted form of strategy training for people with communication impairments who are admitted to inpatient rehabilitation. These analyses will address a critical gap in current rehabilitation research, namely the exclusion of people with communication impairments in acute stroke rehabilitation clinical trials, and provide pilot data to inform the design of future inclusive clinical trials seeking to reduce disability after stroke.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06754566 — A Caregiver-Assisted Rehabilitation With Strategy Training (CAR-ST) for Stroke Patients
· NA
· recruiting
NCT05098730 — Strategy Training and Pets to Promote Stroke Survivor's Cognitive Performance and Community Participation
· NA
· not yet recruiting
NCT06400147 — Strategy Training for Individuals With Unilateral Neglect
· NA
· completed
NCT03913637 — Facilitating Optimal Routines in Aging
· NA
· completed
NCT03792061 — Enhancing Community Participation for Stroke Survivors With Cognitive Impairments
· NA
· active not recruiting
Other University of Pittsburgh trials
Trials by the same sponsor.
NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
· NA
· not yet recruiting
NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation
· not yet recruiting
NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia
· NA
· not yet recruiting
NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus
· NA
· not yet recruiting
NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
Last refreshed: 24 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03593876.